These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Electron microscopic study of the penile plaques and adjacent corpora cavernosa in Peyronie's disease. Hirano D; Takimoto Y; Yamamoto T; Hirakata H; Kawata N Int J Urol; 1997 May; 4(3):274-8. PubMed ID: 9255666 [TBL] [Abstract][Full Text] [Related]
26. Functional tissue engineering of autologous tunica albuginea: a possible graft for Peyronie's disease surgery. Schultheiss D; Lorenz RR; Meister R; Westphal M; Gabouev AI; Mertsching H; Biancosino C; Schlote N; Wefer J; Winkler M; Stief CG; Jonas U Eur Urol; 2004 Jun; 45(6):781-6. PubMed ID: 15149752 [TBL] [Abstract][Full Text] [Related]
27. Electron microscopic findings of penile tissues in veno-occlusive dysfunction: is penile biopsy necessary? Başar M; Sargon MF; Başar H; Celik H; Başar R; Yildiz M; Akalin Z Int Urol Nephrol; 1998; 30(3):331-8. PubMed ID: 9696343 [TBL] [Abstract][Full Text] [Related]
28. Tunica albuginea tissue analysis after electromotive drug administration. Levine LA; Estrada CR; Shou W; Cole A J Urol; 2003 May; 169(5):1775-8. PubMed ID: 12686831 [TBL] [Abstract][Full Text] [Related]
29. The microscopic pathology of Peyronie's disease. Davis CJ J Urol; 1997 Jan; 157(1):282-4. PubMed ID: 8976280 [TBL] [Abstract][Full Text] [Related]
30. Pentoxifylline attenuates transforming growth factor-β1-stimulated collagen deposition and elastogenesis in human tunica albuginea-derived fibroblasts part 1: impact on extracellular matrix. Shindel AW; Lin G; Ning H; Banie L; Huang YC; Liu G; Lin CS; Lue TF J Sex Med; 2010 Jun; 7(6):2077-2085. PubMed ID: 20367772 [TBL] [Abstract][Full Text] [Related]
31. Role of increased transforming growth factor beta protein expression in the pathogenesis of Peyronie's disease. Hassoba H; El-Sakka A; Lue T Egypt J Immunol; 2005; 12(1):1-8. PubMed ID: 16734133 [TBL] [Abstract][Full Text] [Related]
32. A three-dimensional model of the penis for analysis of tissue stresses during normal and abnormal erection. Linder-Ganz E; Gefen A; Elad D; Chen J Ann N Y Acad Sci; 2007 Apr; 1101():464-76. PubMed ID: 17347335 [TBL] [Abstract][Full Text] [Related]
34. Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie's disease. Ferrini MG; Kovanecz I; Nolazco G; Rajfer J; Gonzalez-Cadavid NF BJU Int; 2006 Mar; 97(3):625-33. PubMed ID: 16469038 [TBL] [Abstract][Full Text] [Related]
35. The treatment of loss of penile rigidity associated with Peyronie's disease. Krane RJ Scand J Urol Nephrol Suppl; 1996; 179():147-50. PubMed ID: 8908682 [TBL] [Abstract][Full Text] [Related]
36. Implications of nitric oxide synthase isoforms in the pathophysiology of Peyronie's disease. Bivalacqua TJ; Champion HC; Hellstrom WJ Int J Impot Res; 2002 Oct; 14(5):345-52. PubMed ID: 12454685 [TBL] [Abstract][Full Text] [Related]